Expression of an immunologically reactive merozoite surface protein (MSP-1 42) in E. coli

Biochimica et Biophysica Acta - General Subjects

Volumn 1675, Issue 1-3, 2004, Pages 62-70

  Leung, W H ^a   Meng, Z Q ^b   Hui, G ^c   Ho, W K K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b INSTITUTE OF PLANT PROTECTION AND MICROBIOLOGY   (China)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

Expression; Immunity; Malaria; Merozoite; Surface protein; Vaccine

Indexed keywords

BACTERIAL PROTEIN; HYBRID PROTEIN; MEROZOITE SURFACE PROTEIN 1; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BACTERIUM CULTURE; CONTROLLED STUDY; CROSS REACTION; ESCHERICHIA COLI; IMMUNOGENICITY; IMMUNOLOGY; MOUSE; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BACULOVIRIDAE; CELL PROLIFERATION; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; ESCHERICHIA COLI; GENE EXPRESSION; LYMPHOCYTE ACTIVATION; MALARIA VACCINES; MEROZOITE SURFACE PROTEIN 1; MICE; PEPTIDE FRAGMENTS; PLASMODIUM FALCIPARUM; RABBITS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC;

BACTERIA (MICROORGANISMS); PLASMODIUM FALCIPARUM; UNIDENTIFIED BACULOVIRUS;

EID: 7744241494     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2004.08.005     Document Type: Article

References (40)

1. A.A. Holder, and R.R. Freeman Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody J. Exp. Med. 156 1982 1528 1538
2. A.A. Holder, and R.R. Freeman The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor J. Exp. Med. 160 1984 624 629
3. J.A. Lyon, R.H. Geller, J.D. Haynes, J.D. Chulay, and J.L. Weber Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene Proc. Nat. Acad. Sci. U. S. A. 83 1986 2989 2993
4. M.J. Blackman, H. Whittle, and A.A. Holder Processing of the Plasmodium falciparum merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion Mol. Biochem. Parasitol. 49 1991 35 44
5. M.J. Blackman, I.T. Ling, S.C. Nicholls, and A.A. Holder Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains Mol. Biochem. Parasitol. 49 1991 29 34
6. M.J. Blackman, H.G. Heidrich, S. Donachie, J.S. McBride, and A.A. Holder A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies J. Exp. Med. 172 1990 379 382
7. M.J. Blackman, T.J. Scott-Finnigan, S. Shai, and A.A. Holder Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein J. Exp. Med. 180 1994 389 393
8. J.S. McBride, and H.G. Heidrich Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex Mol. Biochem. Parasitol. 23 1987 71 84
9. S.P. Chang, H.L. Gibson, C.T. Lee-Ng, P.J. Barr, and G.S.N. Hui A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth J. Immunol. 149 1992 548 555
10. T.M. Daly, and C.A. Long A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice Infect. Immun. 61 1993 2462 2467
11. S.P. Chang, S.E. Case, W.L. Gosnell, A. Hashimoto, K.J. Kramer, L.Q. Tam, C.Q. Hashiro, C.M. Nikaido, H.L. Gibson, C.T. Lee-Ng, P.J. Barr, B.T. Yokota, and G.S.N. Hui A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria Infect. Immun. 64 1996 253 261
12. S. Kumar, A. Yadava, D.B. Keister, J.H. Tian, M. Ohl, K.A. Perdue-Greenfield, L.H. Miller, and D.C. Kaslow Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys Mol. Med. 1 1995 325 332
13. A.F. Egan, P. Burghaus, P. Druilhe, A.A. Holder, and E.M. Riley Human antibodies to the 19 kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro Parasite Immunol. 21 1999 133 139
14. D.J. Crisanti, H.M. Muller, C. Hilbich, F. Sinigaglia, H. Matile, M. MacKay, J. Scaife, K. Beyreuther, and H. Bujard Epitopes recognized by human T cells map within the conserved part of gp 190 of Plasmodium falciparum Science 240 1988 1324 1326
15. M. Guttinger, P. Romagnoli, L. Vandel, R. Meloen, B. Takacs, R.J.L. Pink, and F. Sinigaglia HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate Int. Immunol. 3 1991 899 906
16. E.S. Riley, J. Allen, M. Wheeler, S. Blackman, B. Bennett, H. Takacs, H. Schonfeld, A.A. Holder, and B. Greenwood Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP-1) of Plasmodium falciparum are associated with reduced malaria morbidity Parasite Immunol. 14 1992 321 337
17. E.M. Riley, S. Morris-Jones, M.J. Blackman, B.M. Greenwood, and A.A. Holder A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission Parasite Immunol. 15 1993 513 524
18. F. Sinigaglia, B. Takacs, H. Jacot, H. Matile, J.R.L. Pink, A. Crisant, and H. Bujard T cell reactivity against the major merozoite protein of Plasmodium falciparum J. Immunol. 140 1988 3568 3572
19. 19 expressed in S. cerevisiae J. Immunol. 153 1994 2544 2553
20. A.F. Egan, M.J. Blackman, and D.C. Kaslow Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naïve, -exposed and/or -rechallenged Aotus vociferans monkeys Infect. Immun. 68 2000 1417 1418
21. S. Kumar, A. Collins, A. Egan, O. Yadava, M.J. Garraud, J.A. Blackman, C.D. Patino, and D.C. Kaslow Immunogenicity and efficacy in Aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1 Infect. Immun. 68 2000 2215 2223
22. A.W. Stowers, V. Cioce, R.L. Shimp, M. Lawson, G.S.N. Hui, O. Muratova, D. Kaslow, R. Robinson, C.A. Long, and L.H. Miller Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial Infect. Immun. 69 2001 1536 1546
23. A.K. Crisanti, H. Fruh, H.M. Muller, and H. Bujard The T cell reactivity against the major merozoite protein of Plasmodium falciparum Immunol. Lett. 25 1990 143 148
24. L. Kabilan, V. Sharma, P. Kaur, K. Ghosh, R. Yadav, and V. Chauhan Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic Infect. Immun. 62 1994 685 691
25. V. Udhayakumar, D. Anyona, S. Kariuki, Y. Shi, P. Bloland, O. Branch, W. Weiss, B. Nahlen, D. Kaslow, and A. Lal Identification of T and B cell epitopes recognized by humans in the C-terminal 42 kDa domain of the Plasmodium falciparum merozoite surface protein 1 J. Immunol. 154 1995 6022 6030
26. L.Y. Pang, N. Hashimoto, Q. Tam, Z.Q. Meng, G.S.N. Hui, and K.K. Ho In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system Infect. Immun. 70 2002 2772 2779
27. P.H. Bessette, F. Aslund, J. Beckwith, and G. Georgiou Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm Proc. Natl. Acad. Sci. U. S. A. 96 1999 13703 13708
28. W.A. Prinz, F. Aslund, A. Holmgren, and J. Beckwith The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm J. Biol. Chem. 272 1997 15661 15667
29. W.A. Siddiqui, L.Q. Tam, S.C. Kan, K.J. Kramer, S.E. Case, K.L. Palmer, K.M. Yamaga, and G.S.N. Hui Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys Infect. Immun. 52 1986 314 318
30. A. Light, H.S. Savithri, and J.J. Liepnieks Specificity of bovine enterokinase toward protein substrates Anal. Biochem. 106 1980 199 206
31. A.K. Patra, R. Mukhopadhyay, R. Mukhija, A. Krishnan, L.C. Garg, and A.K. Panda Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli Protein Expr. Purif. 18 2000 182 192
32. G.S.N. Hui, A. Hashimoto, and S.P. Chang Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum Infect. Immun. 60 1992 1422 1433
33. S.C. Makrides Strategies for achieving high-level expression of genes in Escherichia coli Microbiol. Rev. 60 1996 512 538
34. L. Vuillard, C. Braun-Breton, and T. Rabilloud Non-detergent sulfobetaines: a new class of mild solubilizing agents for protein purification Biochem. J. 305 1995 337 343
35. L. Vuillard, T. Rabilloud, and M.E. Goldberg Interactions of non-detergent sulfobetaines with early folding intermediates facilitate in vitro protein renaturation Eur. J. Biochem. 256 1998 128 135
36. E.R. LaVallie, E.A. DiBlasio, S. Kovacic, K.L. Grant, P.F. Schendel, and J.M. McCoy A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm Bio/Technology 11 1993 187 193
37. 19, the carboxyl-terminal fragment of the major merozoite surface protein of Plasmodium falciparum Infect. Immun. 63 1995 456 466
38. E. Angov, B.M. Aufiero, A.M. Turgeon, M. Van Handenhove, C.F. Ockenhouse, K.E. Kester, D.S. Walsh, J.S. McBride, M.C. Dubois, J. Cohen, J.D. Haynes, K.H. Eckels, D.G. Heppner, W.R. Ballou, C.L. Diggs, and J.A. Lyon Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine Mol. Biochem. Parasitol. 128 2003 195 204
39. C. Epp, C.W. Kauth, H. Bujard, and R. Lutz Expression and purification of Plasmodium falciparum MSP-142: a malaria vaccine candidate J. Chromatogr., B, Biomed. Sci. Appl. 786 2003 61 72
40. S. Singh, M.C. Kennedy, C.A. Long, A.J. Saul, L.H. Miller, and A.W. Stowers Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1 Infect. Immun. 71 2003 6766 6774